Gastrointestinal transit monitoring and absorption of controlled-release pellets of diltiazem

Pharmaceutical Development and Technology

Volumn 10, Issue 3, 2005, Pages 371-379

  Rahman, Nisar Ur ^a   Yuen, K H ^b   Woei, Wong Jia ^b  

^a THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Diltiazem pellets; Gastrointestinal (GI) transit monitoring; Paracetamol; Sulfasalazine sulfapyridine

Indexed keywords

DILTIAZEM; PARACETAMOL; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; COLON; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG FORMULATION; DRUG MONITORING; DRUG PELLET; DRUG TRANSPORT; GAMMA SCINTIGRAPHY; GASTROINTESTINAL TRANSIT; HUMAN; HUMAN EXPERIMENT; INTESTINE TRANSIT TIME; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RELIABILITY; SMALL INTESTINE; STOMACH EMPTYING;

ACETAMINOPHEN; ADULT; CECUM; DELAYED-ACTION PREPARATIONS; DILTIAZEM; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; MALE; SOLUBILITY; SULFASALAZINE;

EID: 24744446986     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-65680     Document Type: Article

References (13)

1. Peh, K. K.; Yuen, K.H. Indirect gastrointestinal transit monitoring and absorption of theophylline. Int. J. Pharm. 1996, 139, 95-103.
2. Heading, R.C.; Nimmo, J.; Prescott, L.F.; Tothill, P. The dependence of paracetamol absorption on the rate of gastric emptying. Br. J. Pharmacol. 1973, 47, 415-421.
3. Staniforth, D.H.; Coates, P.; Clarke, J.G.N. An HPLC assay for sulfapyridine in plasma and its use to assess small bowel transit time after the administration of sulfasalazine. Int. J. Clin. Pharmacol. Ther. Toxicol. 1987, 25, 406-409.
4. Kellow, J.E.; Borody, T.J.; Phillips, S.F.; Haddad, A.C.; Brown, M.L. Sulfapyridine appearance in plasma after salicylazosulfapyridine. Gastroenterology 1986, 91, 396-400.
5. Wagner, J.G.; Nelson, E. Kinetic analysis of blood levels and urinary excretion in the absorption phase after single doses of drugs. J. Pharm. Sci. 1964, 53, 1392-1403.
6. Kennedy, M.; Chinwah, P.; Wade, D.N. A pharmacological method of measuring mouth caecal transit time in man. Br. J. Clin. Pharmacol. 1979, 8, 372-373.
7. Staniforth, D.H. Comparison of orocaecal transit time assessed by the lactulose/breath hydrogen and the sulfasalazine/sulfapyridine methods. Gut 1989, 30, 978-982.
8. De Sommers, K.; Meyer, E.C.; Van Wyk, M.; Moncrieff, J. Fraction of theophyllinein sustained-release formulation, which is absorbed from the large bowel. Eur. J. Clin. Pharmacol. 1990, 38, 171-173.
9. Gramatte, T.H.; Terhaag, B. The variability of orocecal transit time evaluated by the salicylazosulfapyridine/sulfapyridine method. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991, 29, 147-150.
10. Davis, S.S.; Khosla, R.; Wilson, C.G.; Washington, N. Gastrointestinal transit of a controlled release pellet formulation of tiaprofenic acid and the effect of food. Int. J. Pharm. 1987, 35, 253-258.
11. Wilding, I.R.; Hardy, J.G.; Maccari, M.; Ravelli, V.; Davis, S.S. Scintigraphic and pharmacokinetic assessment of a multiparticulate sustained release formulation of diltiazem. Int. J. Pharm. 1991, 76, 133-143.
12. Abrahamsson, B.; Alpsten, M.; Hugosson, M.; Jonsson, U.E.; Sundgren, M.; Svenheden, A.; Tolli, J. Absorption gastrointestinal transit and tablet erosion of felodipine extended release (ER) tablets. Pharm. Res. 1993, 10, 709-714.
13. Yuen K.H.; Peh, K.K.; Quay, Y.L.; Chan, K.L. A novel simultaneous HPLC assay for serum paracetamol and sulfapyridine as markers of gastric emptying and orocecal transit. Drug Dev. Ind. Pharm. 1997, 23, 225-228.